Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
SANDOZ NEORAL TO REPLACE SANDIMMUNE AS ANTI-ORGAN REJECTION GOLD STANDARD, FIRM SAYS; CYCLOSPORINE MICROEMULSION COST WILL BE SAME AS SANDIMMUNE
Jul 24 1995
•
By
The Pink Sheet
More from Archive
More from Pink Sheet